Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/82928
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Greenwell, T. | - |
dc.contributor.author | Anderson, P. | - |
dc.contributor.author | Madge, S. | - |
dc.contributor.author | Selva-Nayagam, D. | - |
dc.contributor.author | David, D. | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | Clinical and Experimental Ophthalmology, 2014; 42(3):266-270 | - |
dc.identifier.issn | 1442-6404 | - |
dc.identifier.issn | 1442-9071 | - |
dc.identifier.uri | http://hdl.handle.net/2440/82928 | - |
dc.description | Article first published online: 13 SEP 2013 | - |
dc.description.abstract | Background: The study aimed to review the presentation and long-term visual outcomes of patients with orbitotemporal neurofibromatosis. Design: Retrospective case series. Participants: Patients with orbitotemporal neurofibromatosis presenting from 1981 to 2009. Methods: Demographic data, examination findings, causes of vision impairment and interventions performed were recorded for each patient from presentation through subsequent follow-up encounters. Visual impairment was defined as an ipsilateral Snellen acuity of <6/12. Main Outcome Measures: The proportion of patients with visual impairment or enucleation, the rate of new vision loss during follow up; and causes for vision loss or enucleation. Results: Thirty-seven patients (17 female) were included. Median presenting age was 15 years (range 2–45) with an average follow up of 7.4 years (range 0.5–20.3). Visual impairment occurred in 54% of patients at presentation. Causes were amblyopia (13 of 37), optic atrophy (4 of 37), previous enucleation/evisceration (2 of 37), and optic nerve glioma (1 of 37). At presentation, 76% of patients had ptosis, and 51% had strabismus. Thirty-one patients had surgery, with an average of two procedures per patient. At final follow up, 62% had visual impairment. The rate of visual decline was 2% per patient-years. Causes of visual decline were two patients with optic nerve atrophy, one with exposure keratitis and one whose cause was unknown. Five blind patients had enucleation. Conclusions: The first series of orbitotemporal neurofibromatosis to focus on visual outcomes was presented. Vision loss is common, with a high prevalence of amblyopia. Close monitoring from an early age is needed to prevent visual impairment. | - |
dc.description.statementofresponsibility | Timothy H Greenwell, Peter J Anderson, Simon K Madge, Dinesh Selva and David J David | - |
dc.language.iso | en | - |
dc.publisher | Blackwell Publishing Asia | - |
dc.rights | © 2013 Royal Australian and New Zealand College of Ophthalmologists | - |
dc.source.uri | http://dx.doi.org/10.1111/ceo.12179 | - |
dc.subject | craniofacial surgery | - |
dc.subject | neurofibromatosis type 1 | - |
dc.subject | orbitofacial tumours | - |
dc.title | Long-term visual outcomes in patients with orbitotemporal neurofibromatosis | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1111/ceo.12179 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Anderson, P. [0000-0002-3730-4652] | - |
dc.identifier.orcid | Selva-Nayagam, D. [0000-0002-2169-5417] | - |
Appears in Collections: | Aurora harvest Opthalmology & Visual Sciences publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.